Fig. 5: Tumor inflammation heterogeneity in AAM. | Communications Biology

Fig. 5: Tumor inflammation heterogeneity in AAM.

From: Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences

Fig. 5: Tumor inflammation heterogeneity in AAM.

Using a set of 124 inflammation and immune-response genes in AAM, consensus clustering revealed a cluster of patients with high expression of immune genes (CD3, CD45, GZMA, B2M, STAT1), nominating this cluster for immunotherapy treatment intervention. AAM African-American men, APF adverse pathology feature.

Back to article page